| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SEMCDB.2004.05.005 |
| P698 | PubMed publication ID | 15271291 |
| P2093 | author name string | Brigitte Anliker | |
| Jerold Chun | |||
| P433 | issue | 5 | |
| P304 | page(s) | 457-465 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Seminars in Cell & Developmental Biology | Q14330411 |
| P1476 | title | Cell surface receptors in lysophospholipid signaling | |
| P478 | volume | 15 |
| Q34116805 | A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model |
| Q41875386 | A role for S1P signalling in axon guidance in the Xenopus visual system |
| Q42477123 | A transgenic mouse model for the in vivo bioluminescence imaging of the expression of the lysophosphatidic acid receptor 3: relevance for inflammation and uterine physiology research. |
| Q40114967 | Activatory properties of lysophosphatidic acid on human THP-1 cells |
| Q79335185 | Activatory properties of lysophosphatidic acid on human THP-1 cells |
| Q37406736 | Amoeboid chemotaxis: future challenges and opportunities |
| Q55004153 | Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer. |
| Q33278565 | Anti-angiogenic effect of tetraacetyl-phytosphingosine |
| Q38014361 | Anti-fibrosis therapy and diabetic nephropathy |
| Q89691221 | Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate Signaling |
| Q30538938 | Assembly of Fibronectin Extracellular Matrix |
| Q36930924 | Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties |
| Q36907755 | Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways |
| Q37446225 | Autotaxin/lysophospholipase D-mediated lysophosphatidic acid signaling is required to form distinctive large lysosomes in the visceral endoderm cells of the mouse yolk sac. |
| Q36193130 | Beta-catenin, cancer, and G proteins: not just for frizzleds anymore |
| Q30487082 | Biological roles of lysophospholipid receptors revealed by genetic null mice: an update |
| Q39408058 | Brown spider phospholipase-D containing a conservative mutation (D233E) in the catalytic site: identification and functional characterization. |
| Q38981238 | CRE and SRE mediate LPA-induced CCN1 transcription in mouse aortic smooth muscle cells |
| Q36421116 | Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis |
| Q64926607 | Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia. |
| Q42943747 | Deficiency of autotaxin/lysophospholipase D results in head cavity formation in mouse embryos through the LPA receptor-Rho-ROCK pathway |
| Q37333787 | Different Raf protein kinases mediate different signaling pathways to stimulate E3 ligase RFFL gene expression in cell migration regulation |
| Q42522747 | Different mechanisms regulate lysophosphatidic acid (LPA)-dependent versus phorbol ester-dependent internalization of the LPA1 receptor |
| Q39714109 | Effect of S1P5 on proliferation and migration of human esophageal cancer cells |
| Q47334100 | Endogenous Rho-kinase signaling maintains synaptic strength by stabilizing the size of the readily releasable pool of synaptic vesicles. |
| Q36320677 | Expression of sphingosine 1-phosphate receptors in the rat dorsal root ganglia and defined single isolated sensory neurons |
| Q46314163 | Expression patterns of the lysophospholipid receptor genes during mouse early development |
| Q43818963 | FGF7 signals are relayed to autocrine EGF family growth factors to induce branching morphogenesis of mouse salivary epithelium |
| Q37989903 | FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination |
| Q37605148 | Haemodynamics Regulate Fibronectin Assembly via PECAM. |
| Q36871678 | Human cytomegalovirus regulates bioactive sphingolipids |
| Q33821509 | Identification of differentially expressed genes in chickens differing in muscle glycogen content and meat quality |
| Q33819256 | In search of analgesia: emerging roles of GPCRs in pain. |
| Q84341822 | In silico subtraction approach reveals a close lineage relationship between follicular dendritic cells and BP3(hi) stromal cells isolated from SCID mice |
| Q35853199 | Insights into the pharmacological relevance of lysophospholipid receptors |
| Q30429523 | International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature |
| Q37137690 | Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. |
| Q34419164 | Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons |
| Q33825153 | LPA receptor signaling: pharmacology, physiology, and pathophysiology |
| Q43298340 | Lysophosphatidic Acid signals through specific lysophosphatidic Acid receptor subtypes to control key regenerative responses of human gingival and periodontal ligament fibroblasts. |
| Q39237720 | Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index |
| Q33753311 | Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. |
| Q36960382 | Lysophosphatidic acid and renal fibrosis. |
| Q46827764 | Lysophosphatidic acid cooperates with EGF in inducing branching morphogenesis of embryonic mouse salivary epithelium |
| Q42371870 | Lysophosphatidic acid enhances human umbilical cord mesenchymal stem cell viability without differentiation via LPA receptor mediating manner. |
| Q35018207 | Lysophosphatidic acid in vascular development and disease |
| Q43143386 | Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). |
| Q39557258 | Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation |
| Q36246902 | Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha |
| Q36610011 | Lysophosphatidic acid promotes cell migration through STIM1- and Orai1-mediated Ca2+(i) mobilization and NFAT2 activation. |
| Q90422504 | Matrix-Assisted Laser Desorption Ionization Mapping of Lysophosphatidic Acid Changes after Traumatic Brain Injury and the Relationship to Cellular Pathology |
| Q39737398 | Mechanisms of the lysophosphatidic acid-induced increase in [Ca(2+)](i) in skeletal muscle cells |
| Q37444153 | Microarray-assisted fine mapping of quantitative trait loci on chromosome 15 for susceptibility to seizure-induced cell death in mice |
| Q41654981 | Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain |
| Q36528894 | Molecular pathways triggering glioma cell invasion |
| Q43006295 | Non-transactivational, dual pathways for LPA-induced Erk1/2 activation in primary cultures of brown pre-adipocytes |
| Q33809139 | Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells |
| Q37420076 | Oxidized phospholipids in control of inflammation and endothelial barrier |
| Q38817086 | PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells |
| Q36473605 | Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly |
| Q42789241 | Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice |
| Q38505992 | Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression |
| Q42097754 | Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells |
| Q33878267 | Role of TAZ in Lysophosphatidic Acid-Induced Migration and Proliferation of Human Adipose-Derived Mesenchymal Stem Cells |
| Q30499454 | S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells |
| Q46620538 | Serum lipids regulate dendritic cell CD1 expression and function |
| Q46460363 | Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha |
| Q28569220 | Specific receptor subtype mediation of LPA-induced dual effects in cardiac fibroblasts |
| Q46117845 | Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2. |
| Q34127280 | Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions |
| Q36532321 | Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor |
| Q40271531 | Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells |
| Q41980318 | Sphingosine 1-phosphate to p38 signaling via S1P1 receptor and Gαi/o evokes augmentation of capsaicin-induced ionic currents in mouse sensory neurons. |
| Q46703396 | Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone. |
| Q90372497 | Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial): Study protocol for a randomized, placebo-controlled trial |
| Q83387910 | Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase |
| Q46909553 | Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development |
| Q46828825 | Sphingosine-1-phosphate receptor expression and signaling correlate with uterine prostaglandin-endoperoxide synthase 2 expression and angiogenesis during early pregnancy |
| Q34678040 | Sphingosine‐1‐phosphate antibodies as potential agents in the treatment of cancer and age‐related macular degeneration |
| Q41144197 | Spinal cord compression injury in lysophosphatidic acid 1 receptor-null mice promotes maladaptive pronociceptive descending control. |
| Q30541600 | Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. |
| Q42380774 | Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation |
| Q40045072 | The heterotrimeric [corrected] G protein subunit G alpha i is present on mitochondria |
| Q45048548 | The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas. |
| Q34379689 | The sphingosine 1-phosphate receptor, S1PR₁, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons |
| Q36627750 | The tumor microenvironment: key to early detection |
| Q33426563 | Therapeutic strategies for inhibiting invasion in glioblastoma |
| Q35264010 | Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde |
| Q38625631 | Unravelling the interplay of sphingolipids and TGF-β signaling in the human corneal stroma |
Search more.